BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Carvalho KAT, Abdelwahid E, Ferreira RJ, Irioda AC, Guarita-Souza LC. Preclinical stem cell therapy in Chagas Disease: Perspectives for future research. World J Transplant 2013; 3(4): 119-126 [PMID: 24392316 DOI: 10.5500/wjt.v3.i4.119]
URL: https://www.wjgnet.com/2220-3230/full/v3/i4/119.htm
Number Citing Articles
1
Kevin M. Bonney. Chagas disease in the 21st Century: a public health success or an emerging threat?Parasite 2014; 21: 11 doi: 10.1051/parasite/2014012
2
Dayanne da Rocha de Menezes, Claudia Magalhães Calvet, Giseli Capaci Rodrigues, Mirian Claudia de Souza Pereira, Igor Rodrigues Almeida, Alcino Palermo de Aguiar, Claudiu T. Supuran, Alane Beatriz Vermelho. Hydroxamic acid derivatives: a promising scaffold for rational compound optimization in Chagas diseaseJournal of Enzyme Inhibition and Medicinal Chemistry 2016; 31(6): 964 doi: 10.3109/14756366.2015.1077330
3
Khalid Ahmed Al-Anazi, Waleed K. Al-Anazi, Asma M. Al-Jasser. Update on Mesenchymal and Induced Pluripotent Stem Cells2020;  doi: 10.5772/intechopen.91475
4
Al-Anazi Khalid A, Al-Ansari Rehab Y . Update on the Use of Mesenchymal Stem Cells in the Treatment of Various Infectious Diseases Including COVID-19 InfectionJournal of Stem Cell Therapy and Transplantation 2023; 7(1): 034 doi: 10.29328/journal.jsctt.1001033
5
Mehdi Kian, Somayeh Mirzavand, Sedigheh Sharifzadeh, Tahereh Kalantari, Marzieh Ashrafmansouri, Fatemeh Nasri. Efficacy of Mesenchymal Stem Cells Therapy in Parasitic Infections: Are Anti-parasitic Drugs Combined with MSCs More Effective?Acta Parasitologica 2022; 67(4): 1487 doi: 10.1007/s11686-022-00620-7